A Win For Aptevo Therapeutics Inc.
Thu, Mar 24, 2022 at 05:30 PM
Aptevo Therapeutics Inc. (APVO:NASDAQ) jumped higher at $6.96, a gain of 32.8%. On Wed, Mar 23, 2022, APVO:NASDAQ hit a New 2-Week High of $5.24. The stock got featured on our News Catalysts scanner on Thu, Mar 24, 2022 at 10:08 AM in the 'INVESTOR UPDATE' category. From Wed, Mar 09, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Tue, Nov 23, 2021 at $22.08 with a volume of 164M+.
About Aptevo Therapeutics Inc. (APVO:NASDAQ)
Aptevo Therapeutics Inc is a biosciences company. The Company is engaged in the discovery, development, commercialization and sale of novel oncology and hematology therapeutics.
Top 10 Gainers:
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 39.07%
- Global Internet of People Inc. (SDH:NASDAQ), 38.35%
- AgriFORCE Growing Systems Ltd. (AGRI:NASDAQ), 34.89%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 33.67%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 32.82%
- Emclaire Financial Corp (EMCF:NASDAQ), 32.17%
- cbdMD, Inc. (YCBD:NYSEMKT), 31.33%
- NexImmune Inc. (NEXI:NASDAQ), 31.06%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 30.48%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 29.51%